What does CUSIP 004225108 represent in this 13F holders report?

CUSIP 004225108 is the security identifier for ACAD - ACADIA PHARMACEUTICALS INC - Common Stock used to aggregate holder disclosures.

How many institutions held ACAD - ACADIA PHARMACEUTICALS INC - Common Stock in Q2 2017?

199 institutional investors reported ACAD - ACADIA PHARMACEUTICALS INC - Common Stock for Q2 2017. Use the holders table for investor-level position and value details.

ACADIA PHARMACEUTICALS INC - Common Stock (ACAD)

CUSIP: 004225108

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class: Equity / Common Stock
Shares outstanding: 170,504,990
Total 13F shares: 119,784,893
Share change: +3,694,261
Total reported value: $3,339,520,564
Put/Call ratio: 155%
Price per share: $27.89
Number of holders: 199
Value change: +$82,800,071
Number of buys: 106
Number of sells: 97

Quarterly Holders Quick Answers

What is CUSIP 004225108?
CUSIP 004225108 identifies ACAD - ACADIA PHARMACEUTICALS INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2017
Previous quarter: Q1 2017

Recent filing periods for CUSIP 004225108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ACAD - ACADIA PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BAKER BROS. ADVISORS LP	13F	Company	15%	25,819,768	$887,684,000	—	31 Mar 2017	13F
FMR LLC	13F	Company	11%	18,211,143	$626,099,000	—	31 Mar 2017	13F
VANGUARD GROUP INC	13F	Company	4.4%	7,469,785	$256,812,000	—	31 Mar 2017	13F
BlackRock Finance, Inc.	13F	Company	3.2%	5,433,209	$186,791,000	—	31 Mar 2017	13F
OppenheimerFunds, Inc.	13F	Company	2.9%	4,918,286	$169,090,000	—	31 Mar 2017	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	2.7%	4,589,871	$157,800,000	—	31 Mar 2017	13F
FRANKLIN RESOURCES INC	13F	Company	2.1%	3,656,449	$125,709,000	—	31 Mar 2017	13F
JANUS HENDERSON INVESTORS US LLC	13F	Company	2%	3,418,861	$117,539,000	—	31 Mar 2017	13F
STATE STREET CORP	13F	Company	1.9%	3,237,798	$111,319,000	—	31 Mar 2017	13F
WADDELL & REED FINANCIAL INC	13F	Company	1.8%	3,091,977	$106,302,000	—	31 Mar 2017	13F
Capital World Investors	13F	Company	1.5%	2,553,000	$87,772,000	—	31 Mar 2017	13F
FRED ALGER MANAGEMENT, LLC	13F	Company	1.3%	2,180,249	$74,957,000	—	31 Mar 2017	13F
Senator Investment Group LP	13F	Company	1.2%	2,000,000	$68,760,000	—	31 Mar 2017	13F
Point72 Asset Management, L.P.	13F	Company	1.1%	1,931,200	$66,395,000	—	31 Mar 2017	13F
JPMORGAN CHASE & CO	13F	Company	1%	1,786,424	$61,417,000	—	31 Mar 2017	13F
Invesco Ltd.	13F	Company	0.97%	1,646,953	$56,623,000	—	31 Mar 2017	13F
Avoro Capital Advisors LLC	13F	Company	0.96%	1,630,000	$56,039,000	—	31 Mar 2017	13F
Palo Alto Investors LP	13F	Company	0.93%	1,590,430	$54,679,000	—	31 Mar 2017	13F
ORBIMED ADVISORS LLC	13F	Company	0.69%	1,169,000	$40,190,000	—	31 Mar 2017	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.66%	1,122,899	$38,605,000	—	31 Mar 2017	13F
DEUTSCHE BANK AG\	13F	Company	0.64%	1,090,227	$37,478,000	—	31 Mar 2017	13F
NORGES BANK	13F	Company	0.52%	892,884	$30,697,000	—	31 Mar 2017	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.52%	882,722	$30,329,000	—	31 Mar 2017	13F
FIRST TRUST ADVISORS LP	13F	Company	0.51%	871,926	$29,977,000	—	31 Mar 2017	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	0.46%	784,238	$26,962,000	—	31 Mar 2017	13F
ELLIOTT MANAGEMENT CORP	13F	Company	0.46%	777,382	$26,726,000	—	31 Mar 2017	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.45%	760,832	$26,157,000	—	31 Mar 2017	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.42%	710,367	$24,422,417	—	31 Mar 2017	13F
SECTORAL ASSET MANAGEMENT INC	13F	Company	0.39%	671,113	$23,073,000	—	31 Mar 2017	13F
FRONTIER CAPITAL MANAGEMENT CO LLC	13F	Company	0.37%	635,688	$21,855,000	—	31 Mar 2017	13F
ACUTA CAPITAL PARTNERS, LLC	13F	Company	0.34%	572,756	$19,691,000	—	31 Mar 2017	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.33%	566,425	$19,474,000	—	31 Mar 2017	13F
NORTHERN TRUST CORP	13F	Company	0.28%	474,328	$16,307,000	—	31 Mar 2017	13F
CANADA PENSION PLAN INVESTMENT BOARD	13F	Company	0.27%	462,200	$15,890,000	—	31 Mar 2017	13F
JANA PARTNERS LLC	13F	Company	0.25%	421,140	$14,479,000	—	31 Mar 2017	13F
Bank of New York Mellon Corp	13F	Company	0.23%	396,645	$13,636,000	—	31 Mar 2017	13F
Alyeska Investment Group, L.P.	13F	Company	0.22%	372,837	$12,818,000	—	31 Mar 2017	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.21%	364,962	$12,548,000	—	31 Mar 2017	13F
Ghost Tree Capital, LLC	13F	Company	0.21%	350,000	$12,033,000	—	31 Mar 2017	13F
CREDIT SUISSE AG/	13F	Company	0.2%	341,735	$11,749,000	—	31 Mar 2017	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.2%	335,020	$11,519,000	—	31 Mar 2017	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	0.2%	334,700	$11,507,000	—	31 Mar 2017	13F
EDMOND DE ROTHSCHILD HOLDING S.A.	13F	Company	0.19%	316,380	$10,877,000	—	31 Mar 2017	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.18%	306,629	$10,542,000	—	31 Mar 2017	13F
LORD, ABBETT & CO. LLC	13F	Company	0.15%	253,673	$8,721,000	—	31 Mar 2017	13F
WESTFIELD CAPITAL MANAGEMENT CO LP	13F	Company	0.14%	238,694	$8,206,000	—	31 Mar 2017	13F
HARVEY CAPITAL MANAGEMENT INC	13F	Company	0.14%	230,350	$7,919,000	—	31 Mar 2017	13F
VAN ECK ASSOCIATES CORP	13F	Company	0.13%	213,572	$7,343,000	—	31 Mar 2017	13F
GROUP ONE TRADING LLC	13F	Company	0.12%	212,796	$7,316,000	—	31 Mar 2017	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.12%	208,301	$7,161,000	—	31 Mar 2017	13F

Institutional Holders of ACADIA PHARMACEUTICALS INC - Common Stock (ACAD) as of Q2 2017

As of 30 Jun 2017, ACADIA PHARMACEUTICALS INC - Common Stock (ACAD) was held by 199 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 119,784,893 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, FMR LLC, VANGUARD GROUP INC, BlackRock Inc., OppenheimerFunds, Inc., STATE STREET CORP, JANUS HENDERSON GROUP PLC, FRANKLIN RESOURCES INC, PRICE T ROWE ASSOCIATES INC /MD/, and WADDELL & REED FINANCIAL INC. This page lists 199 institutional shareholders reporting positions in this security for the Q2 2017 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2017 vs Q1 2017 Across Filers

Q1 2017 holders

215

Q2 2017 holders

199

Holder diff

-16

Investor	Q1 2017 Shares	Q2 2017 Shares	Share Diff	Share Chg %	Q1 2017 Value $	Q2 2017 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.